Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
JD HEALTH Plunges 5%+ as Nomura Cuts TP to HKD67, Maintains Buy
Recommend 3 Positive 3 Negative 2 |
||||
|
||||
|
JD HEALTH (06618.HK) opened 1.16% lower today, hitting an intraday trough of HKD45.68. It last quoted at HKD45.74, down 5.42%, with turnover of 5.9154 million shares, involving HKD275 million. Nomura issued a research report stating that JD HEALTH's pharmaceutical sales impetus continued and operating profit remained strong. However, a decline in non-operating income weighed on net profit. The broker lowered its TP from HKD80 to HKD67 and maintained a Buy rating. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
